Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF
Titel:
Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF
Auteur:
Aggarwal, Rahul R. Beer, Tomasz M. Weinberg, Vivian K. Higano, Celestia Taplin, Mary-Ellen Ryan, Charles J. Lin, Amy M. Alumkal, Joshi Graff, Julie N. Nordquist, Luke T. Herrera, Isheen Small, Eric J.